Ten-yr renal allograft survival of patients with antiphospholipid antibody syndrome

Clinical Transplantation

Volumn 26, Issue 6, 2012, Pages 853-856

  Vaidya, Smita ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Anti cardiolipin antibodies; Antiphospholipid antibody; Coumadin; ESRD; Low molecular weight heparin

Indexed keywords

CARDIOLIPIN ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING DISORDER; FEMALE; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOSIS;

ADULT; ANTIPHOSPHOLIPID SYNDROME; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84870659161     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2012.01625.x     Document Type: Article

References (12)

1. Vaidya S, Sellers R, Kimball P et al. Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome. Transplantation 2000: 15: 1348.
2. Nzerue CM, Ewav-Lowe K, Pierangeli S, Harris EN. "Black swan in the kidney": renal involvement in antiphospholipid antibody syndrome. Kidney Int 2002: 62: 733.
3. Hughes GR. Thrombosis, abortion, cerebral disease and lupus anticoagulant. BMJ 1983: 287: 1089.
4. Amigo MC, Garcia-Torres R, Robles M et al. Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992: 19: 1181.
5. Vaidya S, Gugliuzza K, Daller JA. Efficacy of anticoagulation therapy in end-stage renal disease patients with antiphospholipid antibody syndrome. Transplantation 2004: 7: 1046.
6. Vaidya S, Daller JA, Gugliuzza K. Role of anti-beta 2 glycoprotien 1 antibodies in ESRD patients with antiphospholipid antibody syndrome. Clin Transplant 2002: 16: 362.
7. Vaidya S, Wang CC, Gugliuzza K, Fish JC. Relative risk of post transplant renal thrombosis in patients with antiphospholipid antibodies Clin Transplant 1998: 12: 439.
8. Khamasta MA, Cuadrado MJ, Mujie F et al. The management of thrombosis in antiphospholipid antibody syndrome. N Engl J Med 1995: 332: 993.
9. Ruiz-Irastorza G, Khamasta MA, Hunt BJ et al. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of series of 66 paients treated with oral anticoagulation to a target international normalized ratio of 3.5. Arch Intern Med 2002: 162: 1164.
10. Tecktonidon MG. Renal involvement in the antiphospholipid syndrome (APS) - APS nephropathy. Clinic Rev Allergy Immunol 2009: 36: 131.
11. Cerilli J, Brasile LM, Galouzis T, Lempert N, Clarke J. The vascular endothelial cell antigen system. Transplantation 1985: 59: 286.
12. Sumitran-Karuppan S, Tyden G, Reinholt F, Berg U, Moller E. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transplant Immunol 1997: 5: 321.